Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 95

Results For "medicine"

2055 News Found

Dimensionless Technologies launches AushadhAI to support pharma supply chain
Digitisation | August 12, 2023

Dimensionless Technologies launches AushadhAI to support pharma supply chain

AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents


Mandaviya addresses BRICS Health Minister’s meeting
News | August 09, 2023

Mandaviya addresses BRICS Health Minister’s meeting

Reiterates India’s commitment to the BRICS TB Research Network Initiative


Govt. passes National Dental Commission Bill, 2023
Policy | August 09, 2023

Govt. passes National Dental Commission Bill, 2023

The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission


Parliament passes National Nursing and Midwifery Commission (NNMC) Bill, 2023
Policy | August 09, 2023

Parliament passes National Nursing and Midwifery Commission (NNMC) Bill, 2023

Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced


USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Drug Approval | August 05, 2023

USFDA approves Merck’s ERVEBO for use in children 12 months of age and older

Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease


Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from 4 more countries
News | August 01, 2023

Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from 4 more countries

The company has secured 506 marketing approvals for its oncology products across 76 countries.


Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Drug Approval | August 01, 2023

Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy


Fluor awarded more than $1 billion in life sciences contracts
News | August 01, 2023

Fluor awarded more than $1 billion in life sciences contracts

Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.


New products and nutraceuticals added under Jan Aushadhi Pariyojana
Policy | July 31, 2023

New products and nutraceuticals added under Jan Aushadhi Pariyojana

The product basket increased to 1800 medicines and 285 Surgical Equipment